Company intelligence / Profile preview

Bluetector

Lucerne, Lucerne, Switzerland

Ownership: Private
Development stage: Other

Overview

Bluetector was a Swiss environmental biotechnology company that developed automated systems for treating heavily polluted wastewater. The company's primary product, the BlueBox, utilized specialized bacteria to decompose organic matter in substances like manure and industrial sludge, converting them into water suitable for irrigation or discharge. Founded in 2012 and headquartered in Lucerne, Bluetector aimed to provide decentralized and cost-effective solutions for the agricultural and industrial sectors. However, the company entered liquidation proceedings around 2020 and is no longer active.

Therapeutic areas: Other
Modalities: Microbial therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Bluetector.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bluetector.

Explore the full profile